Researchers at UCLA have introduced a new technology called SEE-CITE, which significantly improves the ability to identify where small molecules bind to proteins. This advancement builds on an existing method known as photo-crosslinking and allows scientists to map these binding sites with greater precision and reliability. The development has potential implications for accelerating drug discovery and advancing molecular biology research.
The SEE-CITE technology refines the process of photo-crosslinking by enhancing its accuracy in pinpointing interactions between small molecules and proteins. This capability is critical for understanding how drugs interact with their targets at a molecular level, which can inform the design of more effective therapies. Researchers describe this approach as a step forward in addressing challenges associated with studying complex biological systems.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: April 28, 2026
發佈留言